CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

Care payment models CMS introduced in 2025 include six new initiatives targeting drug pricing, chronic disease, and specialty care payments.

Last year saw a sharp acceleration in new models of value-based care launched by the Centers for Medicare and Medicaid ...

CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...

Six states will be testing a new model, developed by the Centers for Medicare and Medicaid Services (CMS), for the federal health program Medicare in 2026. At the end of June, CMS announced the new ...

The Medicare program effectively reduced insulin costs, improved adherence, and increased plan enrollment, benefiting both patients and the federal government. The initiative involved major insulin ...